These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Higher prostate-specific antigen levels predict improved survival in patients with hormone-refractory prostate cancer who have skeletal metastases and normal serum alkaline phosphatase. Xie W, Nakabayashi M, Regan MM, Oh WK. Cancer; 2007 Dec 15; 110(12):2709-15. PubMed ID: 17960608 [Abstract] [Full Text] [Related]
15. An immunohistochemical study of chromogranin A and human epidermal growth factor-2 expression using initial prostate biopsy specimens from patients with bone metastatic prostate cancer. Yamada Y, Nakamura K, Aoki S, Taki T, Naruse K, Matsubara H, Tobiume M, Zennami K, Katsuda R, Honda N. BJU Int; 2007 Jan 15; 99(1):189-95. PubMed ID: 17034504 [Abstract] [Full Text] [Related]
17. Endocrine tumours of the gastrointestinal tract. Transplantation in the management of metastatic endocrine tumours. Pascher A, Klupp J, Neuhaus P. Best Pract Res Clin Gastroenterol; 2005 Aug 15; 19(4):637-48. PubMed ID: 16183532 [Abstract] [Full Text] [Related]